Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the

Gregory D Gromowski1, Alan D T Barrett

  • 1Department of Pathology, Sealy Center for Vaccine Development, Center for Biodefense and Emerging Infectious Diseases, and Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX 77555-0609, USA.

Virology
|August 28, 2007
PubMed